106 related articles for article (PubMed ID: 6800440)
1. Failure of hyposensitisation in treatment of children with grass-pollen asthma.
Hill DJ; Hosking CS; Shelton MJ; Turner MW
Br Med J (Clin Res Ed); 1982 Jan; 284(6312):306-9. PubMed ID: 6800440
[TBL] [Abstract][Full Text] [Related]
2. Growing out of asthma: Clinical and immunological changes over 5 years.
Hill DJ; Hosking CS; Shelton MJ; Turner MW
Lancet; 1981 Dec 19-26; 2(8260-61):1359-62. PubMed ID: 6118755
[TBL] [Abstract][Full Text] [Related]
3. Specific cellular and humoral immunity in children with grass pollen asthma.
Hill DJ; Smart IJ; Hosking CS
Clin Allergy; 1982 Jan; 12(1):83-9. PubMed ID: 7067069
[TBL] [Abstract][Full Text] [Related]
4. Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy.
Machiels JJ; Somville MA; Jacquemin MG; Saint-Remy JM
Allergy; 1991 Jul; 46(5):335-48. PubMed ID: 1928657
[TBL] [Abstract][Full Text] [Related]
5. Childhood asthma: clinical and immunological changes over a decade.
Hill DJ; Hosking CS; Shelton MJ; Turner MW
Clin Exp Allergy; 1991 May; 21(3):343-9. PubMed ID: 1863897
[TBL] [Abstract][Full Text] [Related]
6. IgG antibodies to pollen allergens in children with rye-grass lung sensitivity.
Smart IJ; Hill DJ; Hosking CS
Int Arch Allergy Appl Immunol; 1980; 61(2):245-7. PubMed ID: 7351351
[TBL] [Abstract][Full Text] [Related]
7. Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis.
Ortolani C; Pastorello E; Moss RB; Hsu YP; Restuccia M; Joppolo G; Miadonna A; Cornelli U; Halpern G; Zanussi C
J Allergy Clin Immunol; 1984 Feb; 73(2):283-90. PubMed ID: 6366027
[TBL] [Abstract][Full Text] [Related]
8. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
10. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study.
Rebien W; Puttonen E; Maasch HJ; Stix E; Wahn U
Eur J Pediatr; 1982 Jul; 138(4):341-4. PubMed ID: 7128644
[TBL] [Abstract][Full Text] [Related]
12. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
14. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.
Reid MJ; Moss RB; Hsu YP; Kwasnicki JM; Commerford TM; Nelson BL
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):590-600. PubMed ID: 3771951
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of hayfever and pollen asthma in children with a new, modified allergen extract].
Zimmermann T; Beinder K; Mollet FE; Kroon AM
Immun Infekt; 1990 Aug; 18(4):127-31. PubMed ID: 2210795
[TBL] [Abstract][Full Text] [Related]
16. The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study.
Kuna P; Alam R; Kuzminska B; Rozniecki J
J Allergy Clin Immunol; 1989 Apr; 83(4):816-24. PubMed ID: 2468702
[TBL] [Abstract][Full Text] [Related]
17. IgG subclass antibody markers in grass pollen immunotherapy.
Moss RB
N Engl Reg Allergy Proc; 1987; 8(6):409-15. PubMed ID: 3325818
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
19. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
Yunginger JW; Gleich GJ
J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
[TBL] [Abstract][Full Text] [Related]
20. Allergen-specific IgE and IgG antibodies in pollenallergic children given immunotherapy for 2-6 years.
Foucard T; Johansson SG
Clin Allergy; 1978 May; 8(3):249-57. PubMed ID: 668098
[No Abstract] [Full Text] [Related]
[Next] [New Search]
